- Company strengthens board with experienced senior U.S. defense executive and former U.S. government official
OTTAWA, March 18 /CNW Telbec/ - Allen-Vanguard Corporation (the "Company" or "Allen-Vanguard") (TSX: VRS) of Ottawa, Canada today announced the appointment of Dr. Lawrence J. Cavaiola to its board of directors subject to applicable regulatory and exchange approvals.
Dr. Cavaiola is President of Cavaiola & Associates, LLC, a consulting and advisory services company focusing on the defense, aerospace, and security sectors.
Prior to starting his own company, Dr. Cavaiola held senior positions in both industry and government in the United States. He was Chairman and Chief Executive Officer of Thales North America, Inc., the US operations of the global professional electronics and security company Thales. Before joining Thales he was the founding President of the Northrop Grumman Ship Systems Full Service Center, and also served as Vice President for Strategic and Business Development for Northrop Grumman's shipbuilding sector, including service under Litton Industries ownership. Prior to joining Litton, Dr. Cavaiola held senior positions in business and technology development and strategic planning with both Loral Corporation and Lockheed Martin.
Before moving to the private sector in 1995, Dr. Cavaiola held senior government positions with the United States Congress and Department of Defense. He served as Principal Analyst in the Congressional Budget Office; as a Professional Staff Member and Deputy Staff Director for the Committee on Armed Services of the United States House of Representatives; as Deputy Undersecretary of Defense for Acquisition Operations; and as Special Assistant to the Secretary and Deputy Secretary of Defense.
Dr. Cavaiola spent ten years on active duty with the United States Navy, serving aboard surface combatant ships and as an Assistant Professor at the Naval Postgraduate School. He retired in 1995 as a Captain in the United States Naval Reserve. He is a member of the Chief of Naval Operations Executive Panel and Chaired the Naval Postgraduate School Board of Advisors. His awards include the Department of Defense Medal for Distinguished Public Service and the Legion of Merit.
Dr. Cavaiola graduated with distinction from the United States Naval Academy in 1969. He holds a Master of Science and Ph.D. in Operations Research from The Johns Hopkins University, where he was elected to Phi Beta Kappa.
Current and potential sales of Allen-Vanguard security products into U.S. Department of Defense (DoD) programs are significant, and the Company has for some time had underway a search for a director with U.S. defense sector experience. "We are delighted to welcome Dr. Cavaiola to the board," said David O'Blenis, Chairman of the Allen-Vanguard board of directors. "His background as a former senior U.S. military officer, government official and defense industry executive adds an important perspective at the board level as the Company evolves its strategy in the U.S. defense market."
Forward looking statements
This press release may contain forward-looking statements, which reflect Allen-Vanguard's current expectations regarding future events, its strategy, expected performance and condition. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "expects," "anticipates," "plans," "believes," "estimates" or negative versions thereof and similar expressions. In addition, any statement that may be made concerning future performance, strategies or prospects, and possible future acquisitions or dispositions, is also a forward-looking statement. Forward-looking statements are based on current expectations and projections about future events and are inherently subject to, among other things, risks, uncertainties and assumptions about the Company and economic factors. Forward-looking statements are not promises or guarantees of future performance, and actual events and results could differ materially from those expressed or implied in any forward-looking statements made about the Company. Any number of important factors could contribute to these digressions, including, but not limited to, general economic, political and market factors in North America and internationally, interest and foreign exchange rates, global equity and capital markets, business competition, technological change, changes in government regulations, unexpected judicial or regulatory proceedings, and catastrophic events. We stress that the above-mentioned list of important factors is not exhaustive. We encourage you to consider these and other factors carefully before making any investment decision and we urge you to avoid placing undue reliance on forward-looking statements. Further, you should be aware that the Company disclaims any obligation to publicly update or revise any such forward-looking statements whether as a result of new information, future events or otherwise, prior to the release of the next Management Discussion and Analysis to be released by the Company or except as required by law.
About Allen-Vanguard
Allen-Vanguard Corporation supports the mission of military and homeland security forces around the world with leading proprietary solutions for protection and counter-measures against hazardous devices of all kinds, whether chemical, biological, radiological or explosive (CBRNE), including improvised explosive devices (IEDs) and remotely controlled IEDs (RCIEDs). Allen-Vanguard equipment is in service in more than 120 countries. Products include Electronic Counter-Measures ("ECM") equipment for jamming remote detonation of terrorist devices, specialty security equipment for Explosive Ordnance Disposal ("EOD"), remote intervention robots for hazardous applications, and personal protective wear for use in dealing with explosive and bio-chemical agents. Allen-Vanguard is the developer and/or sole, worldwide licensee of proprietary technologies such as the Med-Eng bomb suit, the Defender(TM) and Vanguard(TM) Mk2 bomb disposal robots, and the Universal Containment System and CASCAD Foam system for blast mitigation and decontamination of bio-chemical warfare agents. Professional services encompass counter-IED intelligence, training and advisory services, including the Triton(TM) Report on terrorist incidents around the world. The Company operates globally through its wholly-owned subsidiaries under the names "Allen-Vanguard", "Med-Eng" and "Hazard Management Solutions". Head office operations are located in Ottawa, Ontario, Canada, with manufacturing operations in Stoney Creek and Pembroke, Ontario; Ogdensburg, New York; Tewkesbury, U.K.; and Cork, Ireland; The Company has professional services operations in Shrivenham, UK, Canada and in the U.S. in Arlington, Virginia, plus sales offices in Canada, the U.S., the U.K. and Asia. Allen-Vanguard's shares are listed on The Toronto Stock Exchange (TSX) under the symbol "VRS".
To find out more about Allen-Vanguard Corporation (TSX: VRS), visit our website at www.allen-vanguard.com.
%SEDAR: 00018026E